Vaxneuvance

Vaccine against pneumococcal infections. The vaccine is injected into the upper arm.

Serotypes: 1,3 , 4 , 5, 6A, 6B,7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F.

Vaccination scheme

Vaccination is given from 6 weeks of age and in adulthood. Adults 1 dose.
Pediatric population here: https://www.ema.europa.eu/en/documents/product-information/vaxneuvance-epar-product-information_cs.pdf

No adult vaccination has been prescribed.

When is it necessary to postpone vaccination?

You must not be acutely ill at the time of vaccination, physical exertion, visiting the sauna, solarium, or large consumption of alcoholic beverages is not recommended on the day of application. The interval between the previous and next vaccination must be at least 2 weeks. You must not take antibiotics at the time of vaccination.

Most commonly reported side effects

Pain at the injection site, mild fever, headache, muscle and joint pain, indigestion, weakness.

Pregnancy, breastfeeding

The administration of Vaxneuvance vaccine in pregnancy should only be considered if the potential benefits
outweigh any potential risks to the mother and fetus. Vaccination of breastfeeding women is a matter for consideration according to the risk of infection.

Notice

All information given here is for information purposes only. The choice of vaccine or vaccination schedule is always up to the doctor after a personal consultation at the vaccination centre.